公开(公告)号：US20170247768A1

公开(公告)日：2017-08-31

申请号：US15588458

申请日：2017-05-05

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Alexander Gutin ,  Susanne Wagner ,  Julia Reid

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/118 ,  C12Q2600/158 ,  G06F19/18 ,  G06F19/24

Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.

公开(公告)号：US20170096712A1

公开(公告)日：2017-04-06

申请号：US15237401

申请日：2016-08-15

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Alexander Gutin ,  Susanne Wagner ,  Julia Reid

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/112 ,  C12Q2600/118 ,  C12Q2600/158 ,  C12Q2600/16 ,  G16B25/00

Abstract: Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.

公开(公告)号：US20220259675A1

公开(公告)日：2022-08-18

申请号：US17678357

申请日：2022-02-23

Applicant: MYRIAD GENETICS, INC.

Inventor： Steven Stone ,  Alexander Gutin ,  Susanne Wagner ,  Julia E. Reid

IPC: C12Q1/6886

Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.

公开(公告)号：US20220112565A1

公开(公告)日：2022-04-14

申请号：US17484179

申请日：2021-09-24

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Alexander Gutin ,  Julia Reid

IPC: C12Q1/6886

Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.

公开(公告)号：US20210071269A1

公开(公告)日：2021-03-11

申请号：US17096755

申请日：2020-11-12

Applicant: MYRIAD GENETICS, INC.

Inventor： Steven Stone ,  Alexander Gutin ,  Susanne Wagner ,  Julia Reid

IPC: C12Q1/6886

Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.

公开(公告)号：US20180265930A1

公开(公告)日：2018-09-20

申请号：US15919394

申请日：2018-03-13

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Alexander Gutin ,  Susanne Wagner ,  Julia Reid

IPC: C12Q1/6886

CPC classification number: C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/118 ,  C12Q2600/158 ,  G16B20/00 ,  G16B40/00

Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.

公开(公告)号：US20170152571A1

公开(公告)日：2017-06-01

申请号：US15349866

申请日：2016-11-11

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Alexander Gutin ,  Julia Reid

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/118 ,  C12Q2600/158

Abstract: Biomarkers and methods using the biomarkers for classifying cancer in a patient (e.g., predicting the risk of cancer-specific death or cancer recurrence) are provided.

公开(公告)号：US20160355884A1

公开(公告)日：2016-12-08

申请号：US15060090

申请日：2016-03-03

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Alexander Gutin ,  Susanne Wagner ,  Julia E. Reid

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/118 ,  C12Q2600/156 ,  C12Q2600/158

Abstract: Biomarkers and methods using the biomarkers for the prediction of the recurrence risk of cancer in a patient are provided.

公开(公告)号：US20160281177A1

公开(公告)日：2016-09-29

申请号：US15171993

申请日：2016-06-02

Applicant: Myriad Genetics, Inc.

Inventor： Steven Stone ,  Julia Reid ,  Eric J. Askeland ,  James A. Brown

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/112 ,  C12Q2600/118 ,  C12Q2600/158 ,  C12Q2600/16

Abstract: Biomarkers and methods using the biomarkers for prognosis of renal cancer in a patient are provided.

Abstract translation: 提供了使用生物标志物对患者的肾癌预后的生物标志物和方法。

公开(公告)号：US20140315935A1

公开(公告)日：2014-10-23

申请号：US14186290

申请日：2014-02-21

Applicant: Myriad Genetics, Inc.

Inventor： Susanne Wagner ,  Steven Stone ,  Alexander Gutin ,  Julia Reid

IPC: C12Q1/68

CPC classification number: C12Q1/6886 ,  C12Q2600/118 ,  C12Q2600/158

Abstract: The invention provides for molecular classification of disease and, particularly, molecular markers for lung cancer prognosis and therapy selection and methods and systems of use thereof.